Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement

NCT03531294 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Retinopathy

Interventions

DRUG: Aflibercept Injection

Sponsor

Greater Houston Retina Research

Collaborators

[object Object]
[object Object]